Flavell D - Search Results

1

Variation in the promoter of the human hormone sensitive lipase gene shows gender specific effects on insulin and lipid levels: results from the Ely study.

Talmud PJ, Palmen J, Luan J, Flavell D, Byrne CD, Waterworth DM, Wareham NJ. Talmud PJ, et al. Among authors: flavell d. Biochim Biophys Acta. 2001 Nov 29;1537(3):239-44. doi: 10.1016/s0925-4439(01)00076-x. Biochim Biophys Acta. 2001. PMID: 11731226 Free article.

2

Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men.

Waterworth DM, Talmud PJ, Luan J, Flavell DM, Byrne CD, Humphries SE, Wareham NJ. Waterworth DM, et al. Among authors: flavell dm. Biochim Biophys Acta. 2003 Apr 17;1637(3):200-6. doi: 10.1016/s0925-4439(03)00021-8. Biochim Biophys Acta. 2003. PMID: 12697301 Free article.

3

Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

Putt W, Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, Humphries SE, Talmud PJ; EARSII group. Putt W, et al. Hum Mol Genet. 2004 Aug 1;13(15):1587-97. doi: 10.1093/hmg/ddh168. Epub 2004 Jun 2. Hum Mol Genet. 2004. PMID: 15175273

4

Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects.

Flavell DM, Pineda Torra I, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller G, Talmud PJ, Staels B, Humphries SE. Flavell DM, et al. Diabetologia. 2000 May;43(5):673-80. doi: 10.1007/s001250051357. Diabetologia. 2000. PMID: 10855543

5

Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.

Talmud PJ, Martin S, Steiner G, Flavell DM, Whitehouse DB, Nagl S, Jackson R, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Humphries SE, Syvänne M; Diabetes Atherosclerosis Intervention Study Investigators. Talmud PJ, et al. Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):644-9. doi: 10.1161/01.ATV.0000065196.61663.8D. Epub 2003 Mar 6. Arterioscler Thromb Vasc Biol. 2003. PMID: 12692006 Clinical Trial.

6

Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth.

Flavell DM, Wootton PT, Myerson SG, World MJ, Pennell DJ, Humphries SE, Talmud PJ, Montgomery HE. Flavell DM, et al. J Mol Med (Berl). 2006 Feb;84(2):126-31. doi: 10.1007/s00109-005-0002-8. Epub 2006 Jan 17. J Mol Med (Berl). 2006. PMID: 16416313 Clinical Trial.

7

Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training.

Wootton PT, Flavell DM, Montgomery HE, World M, Humphries SE, Talmud PJ. Wootton PT, et al. Nutr Metab Cardiovasc Dis. 2007 Jan;17(1):24-31. doi: 10.1016/j.numecd.2005.11.008. Epub 2006 Mar 20. Nutr Metab Cardiovasc Dis. 2007. PMID: 17174223 Clinical Trial.

8

The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.

Talmud PJ, Flavell DM, Alfakih K, Cooper JA, Balmforth AJ, Sivananthan M, Montgomery HE, Hall AS, Humphries SE. Talmud PJ, et al. Clin Sci (Lond). 2007 Jun;112(12):617-24. doi: 10.1042/CS20060344. Clin Sci (Lond). 2007. PMID: 17291198

9

Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.

Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvänne M. Flavell DM, et al. Circulation. 2002 Mar 26;105(12):1440-5. doi: 10.1161/01.cir.0000012145.80593.25. Circulation. 2002. PMID: 11914252

10

Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.

Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ, Ayyobi A, Pimstone S, Frohlich J, Ansquer JC, Steiner G; DAIS investigators. Foucher C, et al. Pharmacogenetics. 2004 Dec;14(12):823-9. doi: 10.1097/00008571-200412000-00005. Pharmacogenetics. 2004. PMID: 15608561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page